117 related articles for article (PubMed ID: 34092618)
1. IGF-1R depletion sensitizes colon cancer cell lines to radiotherapy.
Zong R; Chen X; Feng J; Xu S
Cancer Biomark; 2021; 32(2):199-206. PubMed ID: 34092618
[TBL] [Abstract][Full Text] [Related]
2. SiRNA-mediated IGF-1R inhibition sensitizes human colon cancer SW480 cells to radiation.
Yavari K; Taghikhani M; Maragheh MG; Mesbah-Namin SA; Babaei MH; Arfaee AJ; Madani H; Mirzaei HR
Acta Oncol; 2010; 49(1):70-5. PubMed ID: 20001499
[TBL] [Abstract][Full Text] [Related]
3. IGF-1R inhibition enhances radiosensitivity and delays double-strand break repair by both non-homologous end-joining and homologous recombination.
Chitnis MM; Lodhia KA; Aleksic T; Gao S; Protheroe AS; Macaulay VM
Oncogene; 2014 Nov; 33(45):5262-73. PubMed ID: 24186206
[TBL] [Abstract][Full Text] [Related]
4. Systemic analysis of different colorectal cancer cell lines and TCGA datasets identified IGF-1R/EGFR-PPAR-CASPASE axis as important indicator for radiotherapy sensitivity.
Chen L; Zhu Z; Gao W; Jiang Q; Yu J; Fu C
Gene; 2017 Sep; 627():484-490. PubMed ID: 28687332
[TBL] [Abstract][Full Text] [Related]
5. Suppression of homologous recombination sensitizes human tumor cells to IGF-1R inhibition.
Lodhia KA; Gao S; Aleksic T; Esashi F; Macaulay VM
Int J Cancer; 2015 Jun; 136(12):2961-6. PubMed ID: 25388513
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit.
Raju U; Molkentine DP; Valdecanas DR; Deorukhkar A; Mason KA; Buchholz TA; Meyn RE; Ang KK; Skinner H
Cancer Med; 2015 Jan; 4(1):65-74. PubMed ID: 25355701
[TBL] [Abstract][Full Text] [Related]
7. Depletion of the type 1 IGF receptor delays repair of radiation-induced DNA double strand breaks.
Turney BW; Kerr M; Chitnis MM; Lodhia K; Wang Y; Riedemann J; Rochester M; Protheroe AS; Brewster SF; Macaulay VM
Radiother Oncol; 2012 Jun; 103(3):402-9. PubMed ID: 22551565
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of dose dependent cytotoxic activity in SW480 colon cancer cells by ¹⁷⁷Lu-labeled siRNA targeting IGF-1R.
Fathi M; Taghikhani M; Ghannadi-Maragheh M; Yavari K
Nucl Med Biol; 2013 May; 40(4):529-36. PubMed ID: 23618769
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-type 1 receptor inhibitor NVP-AEW541 enhances radiosensitivity of PTEN wild-type but not PTEN-deficient human prostate cancer cells.
Isebaert SF; Swinnen JV; McBride WH; Haustermans KM
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):239-47. PubMed ID: 21816290
[TBL] [Abstract][Full Text] [Related]
10. Suppression of Homologous Recombination by insulin-like growth factor-1 inhibition sensitizes cancer cells to PARP inhibitors.
Amin O; Beauchamp MC; Nader PA; Laskov I; Iqbal S; Philip CA; Yasmeen A; Gotlieb WH
BMC Cancer; 2015 Oct; 15():817. PubMed ID: 26510816
[TBL] [Abstract][Full Text] [Related]
11. The impact of the IGF-1 system of cancer cells on radiation response - An
Venkatachalam S; Mettler E; Fottner C; Miederer M; Kaina B; Weber MM
Clin Transl Radiat Oncol; 2017 Dec; 7():1-8. PubMed ID: 29594222
[TBL] [Abstract][Full Text] [Related]
12. The insulin-like growth factor-I receptor kinase inhibitor, NVP-ADW742, sensitizes small cell lung cancer cell lines to the effects of chemotherapy.
Warshamana-Greene GS; Litz J; Buchdunger E; García-Echeverría C; Hofmann F; Krystal GW
Clin Cancer Res; 2005 Feb; 11(4):1563-71. PubMed ID: 15746061
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic KRAS drives radioresistance through upregulation of NRF2-53BP1-mediated non-homologous end-joining repair.
Yang L; Shen C; Estrada-Bernal A; Robb R; Chatterjee M; Sebastian N; Webb A; Mo X; Chen W; Krishnan S; Williams TM
Nucleic Acids Res; 2021 Nov; 49(19):11067-11082. PubMed ID: 34606602
[TBL] [Abstract][Full Text] [Related]
14. Lentivirus-mediated RNAi knockdown of insulin-like growth factor-1 receptor inhibits growth, reduces invasion, and enhances radiosensitivity in human osteosarcoma cells.
Wang YH; Wang ZX; Qiu Y; Xiong J; Chen YX; Miao DS; De W
Mol Cell Biochem; 2009 Jul; 327(1-2):257-66. PubMed ID: 19229591
[TBL] [Abstract][Full Text] [Related]
15. The insulin-like growth factor-I (IGF-I) receptor kinase inhibitor NVP-ADW742, in combination with STI571, delineates a spectrum of dependence of small cell lung cancer on IGF-I and stem cell factor signaling.
Warshamana-Greene GS; Litz J; Buchdunger E; Hofmann F; García-Echeverría C; Krystal GW
Mol Cancer Ther; 2004 May; 3(5):527-35. PubMed ID: 15141010
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-375 Inhibits Growth and Enhances Radiosensitivity in Oral Squamous Cell Carcinoma by Targeting Insulin Like Growth Factor 1 Receptor.
Zhang B; Li Y; Hou D; Shi Q; Yang S; Li Q
Cell Physiol Biochem; 2017; 42(5):2105-2117. PubMed ID: 28810236
[TBL] [Abstract][Full Text] [Related]
17. Silencing of insulin-like growth factor-1 receptor enhances the radiation sensitivity of human esophageal squamous cell carcinoma in vitro and in vivo.
Zhao H; Gu X
World J Surg Oncol; 2014 Nov; 12():325. PubMed ID: 25363593
[TBL] [Abstract][Full Text] [Related]
18. Co-inhibition of epidermal growth factor receptor and insulin-like growth factor receptor 1 enhances radiosensitivity in human breast cancer cells.
Li P; Veldwijk MR; Zhang Q; Li ZB; Xu WC; Fu S
BMC Cancer; 2013 Jun; 13():297. PubMed ID: 23777562
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of IGF-IR by RNAi inhibits SW480 colon cancer cells growth in vitro.
Yavari K; Taghikhani M; Maragheh MG; Mesbah-Namin SA; Babaei MH
Arch Med Res; 2009 May; 40(4):235-40. PubMed ID: 19608011
[TBL] [Abstract][Full Text] [Related]
20. Targeting ARID1A-mutant colorectal cancer: depletion of ARID1B increases radiosensitivity and modulates DNA damage response.
Niedermaier B; Sak A; Zernickel E; Xu S; Groneberg M; Stuschke M
Sci Rep; 2019 Dec; 9(1):18207. PubMed ID: 31796878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]